Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 13;8(3):827-828.
doi: 10.1182/bloodadvances.2023012196.

Under AI's lens: spotting mutations visually

Joshua A Fein  1 , Sanjay S Patel  2
Affiliations
Editorial

Under AI's lens: spotting mutations visually

Joshua A Fein et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Figures

None
AI-based diagnostics, as “imagined” by AI. Figure generated with DALL-E (OpenAI) and used as per OpenAI terms of service.
See this image and copyright information in PMC

Comment on

References

    1. Kockwelp J, Thiele S, Bartsch J, et al. Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears. Blood Adv. 2024;8(1):70–79. - PMC - PubMed
    1. Arber DA, Orazi A, Hasserjian RP, et al. International Consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200–1228. - PMC - PubMed
    1. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703–1719. - PMC - PubMed
    1. Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345–1377. - PubMed
    1. Senapati J, Urrutia S, Loghavi S, et al. Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia. Blood. 2023;142(19):1647–1657. - PubMed